Our data uncovered a conditionally sensitive muscle biomarker in Hp, which may be useful as a prognostic tool across other scenarios of chemotherapy‐induced myopathy and cachexia or as a target for therapeutic discovery in follow‐up studies. This evidence concerns the gene HP and Cachexia.